Thanks Rikki
Looks like heading back sub 50c
IMO
Research how biotechs and dilution works - imo plenty of examples to see how retail investors fair over time
IMO
I prefer to read Edison report which indicates upwards of $20m required for a phase 11b trial - only for GDC0084
DYOR